Are “nonsignificant differences” significant?
نویسندگان
چکیده
منابع مشابه
Are Nonsignificant Differences Really Not Significant?
Many researchers and reviewers hesitate to publish data when treatments are not “significantly” different. Most of us were taught to use a particular probability value (usually 5% or 1%) as a critical value to test hypotheses. The term “significant” has come to be synonymous with the phrase “significant at the 5% level.” Using relatively conservative critical values prevents readers from evalua...
متن کاملAre differences in the available aromatase inhibitors and inactivators significant?
Aromatase inhibitors are endocrine agents with a different mode of action than tamoxifen against breast tumors. In postmenopausal women, estrogen concentrations are maintained primarily via aromatase, a cytochrome P-450 enzyme that acts at the final step in the estrogen synthesis pathway. The first clinically available aromatase inhibitor, aminoglutethimide, was introduced for the second-line t...
متن کاملAre Differences in the Available Aromatase Inhibitors and Inactivators Significant?
Aromatase inhibitors are endocrine agents with a different mode of action than tamoxifen against breast tumors. In postmenopausal women, estrogen concentrations are maintained primarily via aromatase, a cytochrome P-450 enzyme that acts at the final step in the estrogen synthesis pathway. The first clinically available aromatase inhibitor, aminoglutethimide, was introduced for the second-line t...
متن کاملAre Differences in the Available Aromatase Inhibitors and Inactivators Significant?
Aromatase inhibitors are endocrine agents with a different mode of action than tamoxifen against breast tumors. In postmenopausal women, estrogen concentrations are maintained primarily via aromatase, a cytochrome P-450 enzyme that acts at the final step in the estrogen synthesis pathway. The first clinically available aromatase inhibitor, aminoglutethimide, was introduced for the second-line t...
متن کاملThe improper use of the words 'significant' and 'nonsignificant' for the classification of coronary atherosclerotic plaques.
2163 and high-risk populations, all tests are more accurate in predicting low than high risk. Few noninvasive tests have the power to predict high-risk populations with annual mortality rates exceeding 20%, which means the high-risk outcome does not occur 80% of the time. In contrast, most physiological tests of ischemia have been documented to reliably define large low-risk groups of populatio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 1996
ISSN: 0735-1097
DOI: 10.1016/0735-1097(96)84777-2